Implantable Defibrillators Market reach nearly USD 5,612.62 million by 2030, exhibiting a robust CAGR of 5.3%
PORTLAND, GA, UNITED STATES, October 9, 2024 /EINPresswire.com/ -- Rise in incidences of heart disorders and advancements in technology such as S-ICDs developed as an alternative to conventional T-ICDs with less potential hazards that drive growth of the implantable defibrillators market.
The global Implantable Defibrillator market size was valued at $3,300.00 million in 2020, and is projected to reach $5,612.62 million by 2030, registering a CAGR of 5.3% from 2021 to 2030.
An implantable defibrillator is an implantable electronic device, which is effective for the treatment of sudden cardiac arrest (SCA) as well as for arrhythmia. The device can be programmed to detect an abnormal heart rate and to deliver shocks as per requirement. Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside patientβs body and perform defibrillation, pacing of heart, and cardioversion. Irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.
Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2091
Increase in incidences of sudden cardiac arrest (SCA) and technological advancements drive the growth of the global implantable defibrillators market. However, high cost and unfavorable reimbursement policies restrain the market growth. On the other hand, increase in demand for ICDs for patients with nonischemic cardiomyopathy presents new opportunities in the coming years.
ππ’π¬π π¨π πππ² ππ₯ππ²ππ«π¬ :
β Abbott
β Biotronik SE & Co. KG
β Boston Scientific Corporation
β Fukuda Denshi Co. Ltd.
β Imricor Medical Systems
β Koninklijke Philips N.V.
β Livanova Plc Company
β Medtronic Plc
β Microport Scientific Corporation
β Nohen Kohden Corporation
Implantable defibrillators are used when the heartbeat is not normal and tries to return the heartbeat to normal. If the ICD has a pacemaker feature when the heartbeat is too slow, it works as a pacemaker and sends tiny electric signals to the heart. When the heartbeat is too fast or chaotic, it gives defibrillation shocks to stop the abnormal rhythm. It works 24 hours a day. New devices also provide pacing to electrically convert a sustained ventricular tachycardia (fast heart rhythm) and backup pacing if bradycardia (slow heart rhythm) occurs. They also offer a host of other sophisticated functions such as storage of detected arrhythmic events and the ability to perform electrophysiologic testing.
The subcutaneous implantable cardioverter defibrillators (S-ICDs) segment to maintain its lead position by 2030
Based on type, the subcutaneous implantable cardioverter defibrillators (S-ICDs) segment accounted for the highest market share in 2020, contributing to more than half of the global implantable defibrillators market, and is expected to maintain its lead position by 2030. This is attributed to its usage for treatment of heart disorders for high precision and targeted functioning. However, the cardiac resynchronization therapy defibrillator (Crt-D) segment is projected to register the highest CAGR of 5.9% during the forecast period, owing to rise in adoption rate with growing incidences of heart diseases and failures.
Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2091
North America to maintain its dominance throughout the forecast period
Based on region, North America contributed to the largest market share in 2020, accounting for nearly two-fifths of the total market share of the global implantable defibrillators market, and is projected to maintain its dominance throughout the forecast period. This is due to surge in incidence of sudden cardiac arrest (SCA), increase in the adoption of S-ICDs, and availability of advanced healthcare facilities. However, Asia-Pacific is estimated to witness the largest CAGR of 6.0% during the forecast period, owing to high population base and improvement in patient awareness about ICD devices.
Key Benefits For Stakeholders:
The study provides an in-depth analysis of the global implantable defibrillator market along with the current trends and future estimations to explain the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the implantable defibrillators market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing implantable defibrillator market opportunities.
Extensive analysis of the key segments of the industry helps to understand the application and products of implantable defibrillators used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the implantable defibrillator market.
Trending Reports in Healthcare Industry (Book Now with Discount):
Internal Trauma Fixation Devices Market https://www.alliedmarketresearch.com/internal-trauma-fixation-devices-market
Multiple Sclerosis Therapies Market https://www.alliedmarketresearch.com/multiple-sclerosis-market
Osteoporosis Drugs Market https://www.alliedmarketresearch.com/osteoporosis-drugs-market
Body Contouring Devices Market https://www.alliedmarketresearch.com/body-contouring-devices-market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
The global Implantable Defibrillator market size was valued at $3,300.00 million in 2020, and is projected to reach $5,612.62 million by 2030, registering a CAGR of 5.3% from 2021 to 2030.
An implantable defibrillator is an implantable electronic device, which is effective for the treatment of sudden cardiac arrest (SCA) as well as for arrhythmia. The device can be programmed to detect an abnormal heart rate and to deliver shocks as per requirement. Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside patientβs body and perform defibrillation, pacing of heart, and cardioversion. Irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.
Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2091
Increase in incidences of sudden cardiac arrest (SCA) and technological advancements drive the growth of the global implantable defibrillators market. However, high cost and unfavorable reimbursement policies restrain the market growth. On the other hand, increase in demand for ICDs for patients with nonischemic cardiomyopathy presents new opportunities in the coming years.
ππ’π¬π π¨π πππ² ππ₯ππ²ππ«π¬ :
β Abbott
β Biotronik SE & Co. KG
β Boston Scientific Corporation
β Fukuda Denshi Co. Ltd.
β Imricor Medical Systems
β Koninklijke Philips N.V.
β Livanova Plc Company
β Medtronic Plc
β Microport Scientific Corporation
β Nohen Kohden Corporation
Implantable defibrillators are used when the heartbeat is not normal and tries to return the heartbeat to normal. If the ICD has a pacemaker feature when the heartbeat is too slow, it works as a pacemaker and sends tiny electric signals to the heart. When the heartbeat is too fast or chaotic, it gives defibrillation shocks to stop the abnormal rhythm. It works 24 hours a day. New devices also provide pacing to electrically convert a sustained ventricular tachycardia (fast heart rhythm) and backup pacing if bradycardia (slow heart rhythm) occurs. They also offer a host of other sophisticated functions such as storage of detected arrhythmic events and the ability to perform electrophysiologic testing.
The subcutaneous implantable cardioverter defibrillators (S-ICDs) segment to maintain its lead position by 2030
Based on type, the subcutaneous implantable cardioverter defibrillators (S-ICDs) segment accounted for the highest market share in 2020, contributing to more than half of the global implantable defibrillators market, and is expected to maintain its lead position by 2030. This is attributed to its usage for treatment of heart disorders for high precision and targeted functioning. However, the cardiac resynchronization therapy defibrillator (Crt-D) segment is projected to register the highest CAGR of 5.9% during the forecast period, owing to rise in adoption rate with growing incidences of heart diseases and failures.
Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2091
North America to maintain its dominance throughout the forecast period
Based on region, North America contributed to the largest market share in 2020, accounting for nearly two-fifths of the total market share of the global implantable defibrillators market, and is projected to maintain its dominance throughout the forecast period. This is due to surge in incidence of sudden cardiac arrest (SCA), increase in the adoption of S-ICDs, and availability of advanced healthcare facilities. However, Asia-Pacific is estimated to witness the largest CAGR of 6.0% during the forecast period, owing to high population base and improvement in patient awareness about ICD devices.
Key Benefits For Stakeholders:
The study provides an in-depth analysis of the global implantable defibrillator market along with the current trends and future estimations to explain the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the implantable defibrillators market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing implantable defibrillator market opportunities.
Extensive analysis of the key segments of the industry helps to understand the application and products of implantable defibrillators used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the implantable defibrillator market.
Trending Reports in Healthcare Industry (Book Now with Discount):
Internal Trauma Fixation Devices Market https://www.alliedmarketresearch.com/internal-trauma-fixation-devices-market
Multiple Sclerosis Therapies Market https://www.alliedmarketresearch.com/multiple-sclerosis-market
Osteoporosis Drugs Market https://www.alliedmarketresearch.com/osteoporosis-drugs-market
Body Contouring Devices Market https://www.alliedmarketresearch.com/body-contouring-devices-market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.